睿智医药 (300149)
ChemPartner PharmaTech Co., Ltd.
K-Line Chart
No K-line data available
Company NameRui Zhi Pharmaceutical Technology Co., Ltd.
Listing Date2010-12-22
Issue Price28RMB
Registered Capital49796.399210k RMB
Legal RepresentativeHu Ruilian
Registered AddressNo. 164 Shengli South Road, Jianghai District, Jiangmen City, Guangdong Province
IndustryHealthcare Services
Main BusinessMicroecological Nutrition Products and Microecological Healthcare & Pharmaceutical R&D Services
Company ProfileRui Zhi Pharmaceutical Technology Co., Ltd. is a group company driven by biotechnological innovation, integrating pharmaceutical R&D services, microecological nutrition, and microecological healthcare businesses.
The group's parent company was established on January 26, 2000, and was listed on the Shenzhen Stock Exchange in 2010 (Stock Code: 300149).
The group owns 5 national high-tech enterprises and has cultivated a leading-scale scientific research service team, comprising over 1,500 R&D personnel, of which approximately 200 hold doctoral degrees.
Stock Details
1. Key Indicators
- Total Shares(W): 49796.40
- Circulating A-Shares(W): 47455.30
- Earnings Per Share(RMB): 0.0142
- Net Assets Per Share(RMB): 2.5174
- Operating Revenue(W RMB): 81684.81
- Total Profit(W RMB): 1474.95
- Net Profit Attributable to Parent(W RMB): 709.13
- Net Profit Growth Rate(%): 111.50
- Weighted Return on Equity(%): 0.5800
- Operating Cash Flow Per Share(RMB): 0.2420
- Undistributed Profit Per Share(RMB): -1.3525
- Capital Reserve Per Share(RMB): 2.4909
2. Main Business
The main business covers:
- Providing drug discovery, development, and production services for global pharmaceutical companies, biotechnology firms, and research institutions.
3. Company Basic Information
- Company Name: Chempartner Pharmatech Co., Ltd.
- Listing Date: 2010-12-22
- Industry: Research and Experimental Development
- Address: 28/F, Trading Plaza, No. 268 Dongfeng Middle Road, Yuexiu District, Guangzhou City, Guangdong Province, China
- Website: www.chempartner.com
- Company Profile：Chempartner Pharmatech Co., Ltd. is a leading pharmaceutical R&D outsourcing service provider (CRO+CDMO business). Adhering to the development philosophy of technology as the foundation, technology first, global operation, and excellent quality, it is committed to continuously empowering innovation in the global pharmaceutical and health industry. It provides integrated new drug R&D and production services covering preclinical R&D (CRO business) and clinical drug development and production (CDMO) for biological and chemical drugs to global pharmaceutical companies, biotechnology R&D companies, and research institutions.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Jiangmen Ruilian Pharmaceutical Investment Co., Ltd. | General Legal Person | 2664.11 | 5.61 |
| 2 | Hong Kong Securities Clearing Company Ltd. | Northbound Funds | 2432.58 | 5.13 |
| 3 | MEGA STAR CENTRE LIMITED | General Legal Person | 2271.13 | 4.79 |
| 4 | Beihai Baben Venture Capital Co., Ltd. | General Legal Person | 1176.76 | 2.48 |
| 5 | Shanghai Ruiyun Enterprise Management Center (Limited Partnership) | General Legal Person | 1052.43 | 2.22 |
| 6 | Shanghai Ruizhao Enterprise Management Center (Limited Partnership) | General Legal Person | 512.40 | 1.08 |
5. Concept Sectors
- Immunotherapy
- CXO Concept
- Sweetener Substitute Concept
- Innovative Drugs
- DeepSeek
- Margin Trading & Securities Lending
- Non-recurring Loss
- Consecutive Losses
- Equity Transfer
- Dispersed Shareholding
- Overseas Business
- Control Change
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information